AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …

Health care is assumed to be a primary good, implying that patients should always demand
or accept treatments that may enhance their life expectancy and quality of life, especially if …

Objective We assessed the hypothesis that mental health conditions (MHCs) are associated
with higher risk of bleeding in patients with atrial fibrillation (AF). Methods The registry-based …

Background and aims We examined temporal trends and age-related differences in the
prevalence of vascular diseases and in their association with ischemic stroke (IS) risk in …

Background Previous studies have shown that education level is associated with the
prognosis of cadaveric kidney transplant recipients. However, it is unclear whether …

Background Low socioeconomic status has been associated with higher risk of ischemic
stroke and death in patients with atrial fibrillation (AF). However, whether socioeconomic …

The importance of social drivers of health (SDOH) in the occurrence, detection, treatment,
and outcome of atrial fibrillation (AF) has attracted increasing attention. Addressing SDOH …

Background Recent practice guidelines favor direct oral anticoagulants (DOACs) over
warfarin for primary stroke prevention in patients with non-valvular atrial fibrillation (NVAF) …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …